Evidence map›Paper›PMID 32642414›Full record

ArticleActa pharmaceutica Sinica. B2020

Zhonghua Wang, Bingshu He, Yaqi Liu, Meiling Huo, Wenqing Fu, Chunyan Yang, Jinfeng Wei, Zeper Abliz

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Spatial Metabolomics and Its Application in Plant Research.International journal of molecular sciences · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Spatial pharmacology using mass spectrometry imaging.Trends in pharmacological sciences · 2024
    Review
  17. Review
  18. Hepatocyte-SpecificDiabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhonghua WangCenter for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing 100081, China.
Bingshu HeCenter for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing 100081, China.
Yaqi LiuCenter for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing 100081, China.
Meiling HuoCenter for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing 100081, China.
Wenqing FuCenter for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing 100081, China.
Chunyan YangNew Drug Safety Evaluation Center, Institute of Materia Medica, Peking Union Medical College, Beijing 100050, China.
Jinfeng WeiNew Drug Safety Evaluation Center, Institute of Materia Medica, Peking Union Medical College, Beijing 100050, China.
Zeper AblizCenter for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing 100081, China.
Minzu University of China · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding of the nephrotoxicity induced by drug candidates is vital to drug discovery and development. Herein, an

Indexed as

AA, aristolochic acidsAAI, aristolochic acids IAAN, AA-induced nephrotoxicityAFADESIAFADESI, air flow-assisted desorption electrospray ionizationAristolochic acidATP, adenosine triphosphateCPT1, xarnitine palmitoyltransferase 1DESI, desorption electrospray ionizationDG, diglycerideGC, gas chromatographHDL, high-density lipoproteinH&E, hematoxylin and eosinIn situ metabolomicsLC, liquid chromatographyLDL, low-density lipoproteinMALDI, matrix-assisted laser desorption ionizationMass spectrometry imagingMG, monoglycerideMSI, mass spectrometry imagingMS, mass spectrometryNephrotoxicityOPLS-DA, orthogonal projections to the latent structures' discriminant analysisPC, phosphatidylcholinePE, phosphatidylethanolaminePG, phosphatidylglycerolPS, phosphatidylserineROI, region of interestRSD, relative standard deviationTG, triglycerideTIC, total ion currentUcr, urine creatinineUpr, urine protein

Identifiers

PMID32642414
PMCPMC7332651
OpenAlexW2996310057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.